Enhancer RNAs in cancer: regulation, mechanisms and therapeutic potential

References

• Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature. 2012;489:101–108.
   PubMed Web of Science ®Google Scholar
• Hangauer MJ, Vaughn IW, McManus MT. Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs. PLoS Genet. 2013;9:e1003569.
   PubMed Web of Science ®Google Scholar
• Natoli G, Andrau JC. Noncoding transcription at enhancers: general principles and functional models. Annu Rev Genet. 2012;46:1–19.
   PubMed Web of Science ®Google Scholar
• Andersson R, Gebhard C, Miguel-Escalada I, et al. An atlas of active enhancers across human cell types and tissues. Nature. 2014;507:455–461.
   PubMed Web of Science ®Google Scholar
• Li W, Notani D, Rosenfeld MG. Enhancers as non-coding RNA transcription units: recent insights and future perspectives. Nat Rev Genet. 2016;17:207–223.
   PubMed Web of Science ®Google Scholar
• Chen H, Li C, Peng X, et al.; Cancer Genome Atlas Research N. A pan-cancer analysis of enhancer expression in nearly 9000 patient samples. Cell. 2018;173:386–99 e12.
   PubMed Web of Science ®Google Scholar
• Schmitt AD, Hu M, Ren B. Genome-wide mapping and analysis of chromosome architecture. Nat Rev Mol Cell Biol. 2016;17:743–755.
   PubMed Web of Science ®Google Scholar
• Murakawa Y, Yoshihara M, Kawaji H, et al. Enhanced identification of transcriptional enhancers provides mechanistic insights into diseases. Trends Genet. 2016;32:76–88.
   PubMed Web of Science ®Google Scholar
• Sur I, Taipale J. The role of enhancers in cancer. Nat Rev Cancer. 2016;16:483–493.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lee J, Ruan H, et al. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer. Nat Commun. 2019;10:4562.
   Web of Science ®Google Scholar
• Tuan D, Kong S, Hu K. Transcription of the hypersensitive site HS2 enhancer in erythroid cells. Proc Natl Acad Sci U S A. 1992;89:11219–11223.
   PubMed Web of Science ®Google Scholar
• De Santa F, Barozzi I, Mietton F, et al. A large fraction of extragenic RNA pol II transcription sites overlap enhancers. PLoS Biol. 2010;8:e1000384.
   PubMed Web of Science ®Google Scholar
• Kim TK, Hemberg M, Gray JM, et al. Widespread transcription at neuronal activity-regulated enhancers. Nature. 2010;465:182–187.
   PubMed Web of Science ®Google Scholar
• Allen MA, Andrysik Z, Dengler VL, et al. Global analysis of p53-regulated transcription identifies its direct targets and unexpected regulatory mechanisms. Elife. 2014;3:e02200.
   PubMed Web of Science ®Google Scholar
• Alvarez-Dominguez JR, Hu W, Yuan B, et al. Global discovery of erythroid long noncoding RNAs reveals novel regulators of red cell maturation. Blood. 2014;123:570–581.
   PubMed Web of Science ®Google Scholar
• Arner E, Daub CO, Vitting-Seerup K, et al. Transcribed enhancers lead waves of coordinated transcription in transitioning mammalian cells. Science. 2015;347:1010–1014.
   PubMed Web of Science ®Google Scholar
• Lai F, Gardini A, Zhang A, et al. Integrator mediates the biogenesis of enhancer RNAs. Nature. 2015;525:399–403.
   PubMed Web of Science ®Google Scholar
• Lam MT, Cho H, Lesch HP, et al. Rev-Erbs repress macrophage gene expression by inhibiting enhancer-directed transcription. Nature. 2013;498:511–515.
   PubMed Web of Science ®Google Scholar
• Li W, Notani D, Ma Q, et al. Functional roles of enhancer RNAs for oestrogen-dependent transcriptional activation. Nature. 2013;498:516–520.
   PubMed Web of Science ®Google Scholar
• Sigova AA, Mullen AC, Molinie B, et al. Divergent transcription of long noncoding RNA/mRNA gene pairs in embryonic stem cells. Proc Natl Acad Sci U S A. 2013;110:2876–2881.
   PubMed Web of Science ®Google Scholar
• Hah N, Danko CG, Core L, et al. A rapid, extensive, and transient transcriptional response to estrogen signaling in breast cancer cells. Cell. 2011;145:622–634.
   PubMed Web of Science ®Google Scholar
• Lam MT, Li W, Rosenfeld MG, et al. Enhancer RNAs and regulated transcriptional programs. Trends Biochem Sci. 2014;39:170–182.
   PubMed Web of Science ®Google Scholar
• Koch F, Fenouil R, Gut M, et al. Transcription initiation platforms and GTF recruitment at tissue-specific enhancers and promoters. Nat Struct Mol Biol. 2011;18:956–963.
   PubMed Web of Science ®Google Scholar
• Core LJ, Waterfall JJ, Lis JT. Nascent RNA sequencing reveals widespread pausing and divergent initiation at human promoters. Science. 2008;322:1845–1848.
   PubMed Web of Science ®Google Scholar
• Kwak H, Fuda NJ, Core LJ, et al. Precise maps of RNA polymerase reveal how promoters direct initiation and pausing. Science. 2013;339:950–953.
   PubMed Web of Science ®Google Scholar
• Schwalb B, Michel M, Zacher B, et al. TT-seq maps the human transient transcriptome. Science. 2016;352:1225–1228.
   PubMed Web of Science ®Google Scholar
• Core LJ, Martins AL, Danko CG, et al. Analysis of nascent RNA identifies a unified architecture of initiation regions at mammalian promoters and enhancers. Nat Genet. 2014;46:1311–1320.
   PubMed Web of Science ®Google Scholar
• Wang D, Garcia-Bassets I, Benner C, et al. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA. Nature. 2011;474:390–394.
   PubMed Web of Science ®Google Scholar
• Lai F, Orom UA, Cesaroni M, et al. Activating RNAs associate with mediator to enhance chromatin architecture and transcription. Nature. 2013;494:497–501.
   PubMed Web of Science ®Google Scholar
• Hsieh CL, Fei T, Chen Y, et al. Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation. Proc Natl Acad Sci U S A. 2014;111:7319–7324.
   PubMed Web of Science ®Google Scholar
• Schaukowitch K, Joo JY, Liu X, et al. Enhancer RNA facilitates NELF release from immediate early genes. Mol Cell. 2014;56:29–42.
   PubMed Web of Science ®Google Scholar
• Sigova AA, Abraham BJ, Ji X, et al. Transcription factor trapping by RNA in gene regulatory elements. Science. 2015;350:978–981.
   PubMed Web of Science ®Google Scholar
• Adelman K, Lis JT. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet. 2012;13:720–731.
   PubMed Web of Science ®Google Scholar
• Gonen N, Futtner CR, Wood S, et al. Sex reversal following deletion of a single distal enhancer of Sox9. Science. 2018;360:1469–1473.
   PubMed Web of Science ®Google Scholar
• Osterwalder M, Barozzi I, Tissieres V, et al. Enhancer redundancy provides phenotypic robustness in mammalian development. Nature. 2018;554:239–243.
   PubMed Web of Science ®Google Scholar
• Ho Y, Elefant F, Liebhaber SA, et al. Locus control region transcription plays an active role in long-range gene activation. Mol Cell. 2006;23:365–375.
   PubMed Web of Science ®Google Scholar
• Paralkar VR, Taborda CC, Huang P, et al. Unlinking an lncRNA from its associated cis element. Mol Cell. 2016;62:104–110.
   PubMed Web of Science ®Google Scholar
• Mumbach MR, Satpathy AT, Boyle EA, et al. Enhancer connectome in primary human cells identifies target genes of disease-associated DNA elements. Nat Genet. 2017;49:1602–1612.
   PubMed Web of Science ®Google Scholar
• Mousavi K, Zare H, Dell’orso S, et al. eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci. Mol Cell. 2013;51:606–617.
   PubMed Web of Science ®Google Scholar
• Melo CA, Drost J, Wijchers PJ, et al. eRNAs are required for p53-dependent enhancer activity and gene transcription. Mol Cell. 2013;49:524–535.
   PubMed Web of Science ®Google Scholar
• Pefanis E, Wang J, Rothschild G, et al. RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. Cell. 2015;161:774–789.
   PubMed Web of Science ®Google Scholar
• Ounzain S, Pezzuto I, Micheletti R, et al. Functional importance of cardiac enhancer-associated noncoding RNAs in heart development and disease. J Mol Cell Cardiol. 2014;76:55–70.
   PubMed Web of Science ®Google Scholar
• Kopp F, Mendell JT. Functional classification and experimental dissection of long noncoding RNAs. Cell. 2018;172:393–407.
   PubMed Web of Science ®Google Scholar
• Tsai PF, Dell’Orso S, Rodriguez J, et al. A muscle-specific enhancer RNA mediates cohesin recruitment and regulates transcription in trans. Mol Cell. 2018;71:129–41 e8.
   PubMed Web of Science ®Google Scholar
• Bonasio R, Shiekhattar R. Regulation of transcription by long noncoding RNAs. Annu Rev Genet. 2014;48:433–455.
   PubMed Web of Science ®Google Scholar
• Miao Y, Ajami NE, Huang TS, et al. Enhancer-associated long non-coding RNA LEENE regulates endothelial nitric oxide synthase and endothelial function. Nat Commun. 2018;9:292.
   PubMed Web of Science ®Google Scholar
• Orom UA, Derrien T, Beringer M, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010;143:46–58.
   PubMed Web of Science ®Google Scholar
• Wang KC, Yang YW, Liu B, et al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature. 2011;472:120–124.
   PubMed Web of Science ®Google Scholar
• Espinosa JM. Revisiting lncRNAs: how do you know yours is not an eRNA? Mol Cell. 2016;62:1–2.
   PubMed Web of Science ®Google Scholar
• Wu X, Sharp PA. Divergent transcription: a driving force for new gene origination? Cell. 2013;155:990–996.
   PubMed Web of Science ®Google Scholar
• Espinosa JM. On the origin of lncRNAs: missing link found. Trends Genet. 2017;33:660–662.
   PubMed Web of Science ®Google Scholar
• Herz HM, Hu D, Shilatifard A. Enhancer malfunction in cancer. Mol Cell. 2014;53:859–866.
   PubMed Web of Science ®Google Scholar
• Flavahan WA, Gaskell E, Bernstein BE. Epigenetic plasticity and the hallmarks of cancer. Science. 2017;357:6348:eaal2380.
   Web of Science ®Google Scholar
• Feinberg AP, Koldobskiy MA, Gondor A. Epigenetic modulators, modifiers and mediators in cancer aetiology and progression. Nat Rev Genet. 2016;17:284–299.
   PubMed Web of Science ®Google Scholar
• Hnisz D, Schuijers J, Lin CY, et al. Convergence of developmental and oncogenic signaling pathways at transcriptional super-enhancers. Mol Cell. 2015;58:362–370.
   PubMed Web of Science ®Google Scholar
• Loven J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013;153:320–334.
   PubMed Web of Science ®Google Scholar
• Parker SC, Stitzel ML, Taylor DL, et al. Chromatin stretch enhancer states drive cell-specific gene regulation and harbor human disease risk variants. Proc Natl Acad Sci U S A. 2013;110:17921–17926.
   PubMed Web of Science ®Google Scholar
• McCleland ML, Mesh K, Lorenzana E, et al. CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016;126:639–652.
   PubMed Web of Science ®Google Scholar
• Xiang JF, Yin QF, Chen T, et al. Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus. Cell Res. 2014;24:513–531.
   PubMed Web of Science ®Google Scholar
• van der Steen T, Tindall DJ, Huang H. Posttranslational modification of the androgen receptor in prostate cancer. Int J Mol Sci. 2013;14:14833–14859.
   PubMed Web of Science ®Google Scholar
• Rahnamoun H, Lu H, Duttke SH, et al. Mutant p53 shapes the enhancer landscape of cancer cells in response to chronic immune signaling. Nat Commun. 2017;8:754.
   PubMed Web of Science ®Google Scholar
• Rahnamoun H, Lee J, Sun Z, et al. RNAs interact with BRD4 to promote enhanced chromatin engagement and transcription activation. Nat Struct Mol Biol. 2018;25:687–697.
   PubMed Web of Science ®Google Scholar
• Hah N, Benner C, Chong LW, et al. Inflammation-sensitive super enhancers form domains of coordinately regulated enhancer RNAs. Proc Natl Acad Sci U S A. 2015;112:E297–302.
   PubMed Web of Science ®Google Scholar
• Moreau PR, Ord T, Downes NL, et al. Transcriptional profiling of hypoxia-regulated non-coding RNAs in human primary endothelial cells. Front Cardiovasc Med. 2018;5:159.
   PubMed Web of Science ®Google Scholar
• Ko JY, Oh S, Yoo KH. Functional enhancers as master regulators of tissue-specific gene regulation and cancer development. Mol Cells. 2017;40:169–177.
   PubMed Web of Science ®Google Scholar
• Meng Z, Moroishi T, Guan KL. Mechanisms of hippo pathway regulation. Genes Dev. 2016;30:1–17.
   PubMed Web of Science ®Google Scholar
• Galli GG, Carrara M, Yuan WC, et al. YAP drives growth by controlling transcriptional pause release from dynamic enhancers. Mol Cell. 2015;60:328–337.
   PubMed Web of Science ®Google Scholar
• Wang H, Zang C, Taing L, et al. NOTCH1-RBPJ complexes drive target gene expression through dynamic interactions with super enhancers. Proc Natl Acad Sci U S A. 2014;111:705–710.
   PubMed Web of Science ®Google Scholar
• Skalska L, Stojnic R, Li J, et al. Chromatin signatures at Notch-regulated enhancers reveal large-scale changes in H3K56ac upon activation. Embo J. 2015;34:1889–1904.
   PubMed Web of Science ®Google Scholar
• Dang CV. MYC on the path to cancer. Cell. 2012;149:22–35.
   PubMed Web of Science ®Google Scholar
• Leveille N, Melo CA, Rooijers K, et al. Genome-wide profiling of p53-regulated enhancer RNAs uncovers a subset of enhancers controlled by a lncRNA. Nat Commun. 2015;6:6520.
   PubMed Web of Science ®Google Scholar
• Liang J, Shang Y. Estrogen and cancer. Annu Rev Physiol. 2013;75:225–240.
   PubMed Web of Science ®Google Scholar
• Watson PA, Arora VK, Sawyers CL. Emerging mechanisms of resistance to androgen receptor inhibitors in prostate cancer. Nat Rev Cancer. 2015;15:701–711.
   PubMed Web of Science ®Google Scholar
• Hah N, Murakami S, Nagari A, et al. Enhancer transcripts mark active estrogen receptor binding sites. Genome Res. 2013;23:1210–1223.
   PubMed Web of Science ®Google Scholar
• Murakami S, Nagari A, Kraus WL. Dynamic assembly and activation of estrogen receptor alpha enhancers through coregulator switching. Genes Dev. 2017;31:1535–1548.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang L, Ren S, et al. Activation of P-TEFb by androgen receptor-regulated enhancer RNAs in castration-resistant prostate cancer. Cell Rep. 2016;15:599–610.
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. Inflammation and cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27–41.
   PubMed Web of Science ®Google Scholar
• Brown JD, Lin CY, Duan Q, et al. NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol Cell. 2014;56:219–231.
   PubMed Web of Science ®Google Scholar
• Muz B, de la Puente P, Azab F, et al. The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy. Hypoxia (Auckl). 2015;3:83–92.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Dor Y, Herbert JM, et al. Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998;394:485–490.
   PubMed Web of Science ®Google Scholar
• Grampp S, Platt JL, Lauer V, et al. Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer. Nat Commun. 2016;7:13183.
   PubMed Web of Science ®Google Scholar
• Chen X, Iliopoulos D, Zhang Q, et al. XBP1 promotes triple-negative breast cancer by controlling the HIF1alpha pathway. Nature. 2014;508:103–107.
   PubMed Web of Science ®Google Scholar
• Magnani L, Stoeck A, Zhang X, et al. Genome-wide reprogramming of the chromatin landscape underlies endocrine therapy resistance in breast cancer. Proc Natl Acad Sci U S A. 2013;110:E1490–9.
   PubMed Web of Science ®Google Scholar
• Zhu C, Li L, Zhang Z, et al. A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer. Mol Cell. 2019;75:791–806 e8.
   PubMed Web of Science ®Google Scholar
• Jiao W, Chen Y, Song H, et al. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis. Oncogene. 2018;37:2728–2745.
   PubMed Web of Science ®Google Scholar
• Tan SH, Leong WZ, Ngoc PCT, et al. The enhancer RNA ARIEL activates the oncogenic transcriptional program in T-cell acute lymphoblastic leukemia. Blood. 2019;134:239–251.
   PubMed Web of Science ®Google Scholar
• Bose DA, Donahue G, Reinberg D, et al. RNA binding to CBP stimulates histone acetylation and transcription. Cell. 2017;168:135–49 e22.
   PubMed Web of Science ®Google Scholar
• Shii L, Song L, Maurer K, et al. SERPINB2 is regulated by dynamic interactions with pause-release proteins and enhancer RNAs. Mol Immunol. 2017;88:20–31.
   PubMed Web of Science ®Google Scholar
• Shi L, Li S, Maurer K, et al. Enhancer RNA and NFkappaB-dependent P300 regulation of ADAMDEC1. Mol Immunol. 2018;103:312–321.
   PubMed Web of Science ®Google Scholar
• Sanz LA, Hartono SR, Lim YW, et al. Prevalent, dynamic, and conserved r-loop structures associate with specific epigenomic signatures in mammals. Mol Cell. 2016;63:167–178.
   PubMed Web of Science ®Google Scholar
• Thomas M, White RL, Davis RW. Hybridization of RNA to double-stranded DNA: formation of R-loops. Proc Natl Acad Sci U S A. 1976;73:2294–2298.
   PubMed Web of Science ®Google Scholar
• Gan W, Guan Z, Liu J, et al. R-loop-mediated genomic instability is caused by impairment of replication fork progression. Genes Dev. 2011;25:2041–2056.
   PubMed Web of Science ®Google Scholar
• Bhatia V, Barroso SI, Garcia-Rubio ML, et al. BRCA2 prevents R-loop accumulation and associates with TREX-2 mRNA export factor PCID2. Nature. 2014;511:362–365.
   PubMed Web of Science ®Google Scholar
• Paulsen RD, Soni DV, Wollman R, et al. A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. Mol Cell. 2009;35:228–239.
   PubMed Web of Science ®Google Scholar
• Lubas M, Andersen PR, Schein A, et al. The human nuclear exosome targeting complex is loaded onto newly synthesized RNA to direct early ribonucleolysis. Cell Rep. 2015;10:178–192.
   PubMed Web of Science ®Google Scholar
• Kilchert C, Wittmann S, Vasiljeva L. The regulation and functions of the nuclear RNA exosome complex. Nat Rev Mol Cell Biol. 2016;17:227–239.
   PubMed Web of Science ®Google Scholar
• Gu X, Wang L, Boldrup L, et al. AP001056.1, A prognosis-related enhancer RNA in squamous cell carcinoma of the head and neck. Cancers (Basel). 2019;11:347.
   Web of Science ®Google Scholar
• Stadler ME, Patel MR, Couch ME, et al. Molecular biology of head and neck cancer: risks and pathways. Hematol Oncol Clin North Am. 2008;22: 1099–1124. .
   PubMed Web of Science ®Google Scholar
• Thibaudeau E, Fortin B, Coutlee F, et al. HPV prevalence and prognostic value in a prospective cohort of 255 patients with locally advanced HNSCC: a single-centre experience. Int J Otolaryngol. 2013;2013:437815.
   PubMedGoogle Scholar
• Zhang X, Choi PS, Francis JM, et al. Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers. Nat Genet. 2016;48:176–182.
   PubMed Web of Science ®Google Scholar
• Bahr C, von Paleske L, Uslu VV, et al. A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies. Nature. 2018;553:515–520.
   PubMed Web of Science ®Google Scholar
• Mansour MR, Abraham BJ, Anders L, et al. Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science. 2014;346:1373–1377.
   PubMed Web of Science ®Google Scholar
• Corces MR, Granja JM, Shams S, et al. The chromatin accessibility landscape of primary human cancers. Science. 2018;362(6413): eaav1898.
   PubMed Web of Science ®Google Scholar
• Liang J, Zhou H, Gerdt C, et al. Epstein-Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferation. Proc Natl Acad Sci U S A. 2016;113:14121–14126.
   PubMed Web of Science ®Google Scholar
• Ding M, Zhan H, Liao X, et al. Enhancer RNA - P2RY2e induced by estrogen promotes malignant behaviors of bladder cancer. Int J Biol Sci. 2018;14:1268–1276.
   PubMed Web of Science ®Google Scholar
• McHugh CA, Chen CK, Chow A, et al. The Xist lncRNA interacts directly with SHARP to silence transcription through HDAC3. Nature. 2015;521:232–236.
   PubMed Web of Science ®Google Scholar
• Minajigi A, Froberg J, Wei C, et al. Chromosomes. A comprehensive Xist interactome reveals cohesin repulsion and an RNA-directed chromosome conformation. Science. 2015;349(6245), aab2276.
   Web of Science ®Google Scholar
• Chu C, Zhang QC, da Rocha ST, et al. Systematic discovery of Xist RNA binding proteins. Cell. 2015;161:404–416.
   PubMed Web of Science ®Google Scholar
• Han L, Diao L, Yu S, et al. The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell. 2015;28:515–528.
   PubMed Web of Science ®Google Scholar
• Batista PJ, Molinie B, Wang J, et al. m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells. Cell Stem Cell. 2014;15:707–719.
   PubMed Web of Science ®Google Scholar
• Meyer KD, Jaffrey SR. Rethinking m(6)A readers, writers, and erasers. Annu Rev Cell Dev Biol. 2017;33:319–342.
   PubMed Web of Science ®Google Scholar
• Liu N, Dai Q, Zheng G, et al. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature. 2015;518:560–564.
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu Z, Yi J, et al. The tRNA methyltransferase NSun2 stabilizes p16INK(4) mRNA by methylating the 3ʹ-untranslated region of p16. Nat Commun. 2012;3:712.
   PubMed Web of Science ®Google Scholar
• Liu RJ, Long T, Li J, et al. Structural basis for substrate binding and catalytic mechanism of a human RNA: m5Cmethyltransferase NSun6. Nucleic Acids Res. 2017;45:6684–6697.
   PubMed Web of Science ®Google Scholar
• Delatte B, Wang F, Ngoc LV, et al. RNA biochemistry. Transcriptome-wide distribution and function of RNA hydroxymethylcytosine. Science. 2016;351:282–285.
   PubMed Web of Science ®Google Scholar
• Roovers M, Wouters J, Bujnicki JM, et al. A primordial RNA modification enzyme: the case of tRNA (m1A) methyltransferase. Nucleic Acids Res. 2004;32:465–476.
   PubMed Web of Science ®Google Scholar
• Aguilo F, Li S, Balasubramaniyan N, et al. Deposition of 5-methylcytosine on enhancer RNAs enables the coactivator function of PGC-1alpha. Cell Rep. 2016;14:479–492.
   PubMed Web of Science ®Google Scholar
• Zamft B, Bintu L, Ishibashi T, et al. Nascent RNA structure modulates the transcriptional dynamics of RNA polymerases. Proc Natl Acad Sci U S A. 2012;109:8948–8953.
   PubMed Web of Science ®Google Scholar
• Li X, Fu XD. Chromatin-associated RNAs as facilitators of functional genomic interactions. Nat Rev Genet. 2019;20:503–519.
   PubMed Web of Science ®Google Scholar
• Xiao R, Chen JY, Liang Z, et al. Pervasive chromatin-RNA binding protein interactions enable RNA-based regulation of transcription. Cell. 2019;178:107–21 e18.
   PubMed Web of Science ®Google Scholar
• Fay MM, Anderson PJ. The role of RNA in biological phase separations. J Mol Biol. 2018;430:4685–4701.
   PubMed Web of Science ®Google Scholar
• Lin Y, Protter DS, Rosen MK, et al. Formation and maturation of phase-separated liquid droplets by RNA-binding proteins. Mol Cell. 2015;60:208–219.
   PubMed Web of Science ®Google Scholar
• Hnisz D, Shrinivas K, Young RA, et al. A phase separation model for transcriptional control. Cell. 2017;169:13–23.
   PubMed Web of Science ®Google Scholar